Pharmacovigilance challenges in Biosimilars


This session of the Biosimilars 2022 will investigate the future and FDA activities that have just been declared to incorporate upgraded following and follow-up of post promoting observation issues, arranged enhancements in AERS, and pilots of new post market drug-monitoring strategies and ADR related issues. Biosimilar rules for pharmacovigilance practice and pharmacoepidemiology are the focuses that will be laid emphasis in this session. U.S. normal yearly spending development from 2002 to 2007 was 16% for biologics, contrasted and 3.7% for drugs. In same extent pharmacovigilance for biosimilar has been nearly more than other pharmaceutical items.

Current issues in biosimilars pharmacovigilance

  1. Unfriendly medication responses with biologics and biosimilar items
  2. Recognition and assessment of medication security signals
  3. Job of pharma businesses in the improvement of pharmacovigilance framework
  4. Great pharmacovigilance practice and pharmacoepidemiology

    Related Conference of Pharmacovigilance challenges in Biosimilars

    April 04-05, 2024

    17th European Biosimilars Congress

    Madrid, Spain
    April 11-12, 2024

    5th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE

    Pharmacovigilance challenges in Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in